The pros and cons for Commonwealth Bank of Australia shares

Is the bank a worthy investment to consider?

| More on:

You鈥檙e reading a free article with opinions that may differ from The Motley Fool鈥檚 Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Commonwealth Bank of Australia (ASX: CBA) was one of the ASX鈥檚 strongest blue-chip stocks last financial year, having posted a capital gain of 17% (or 22.5% when dividends are included). While they are now trading just 1.5% below their all-time high of $82.68, are they worth your attention in this new financial year?

Here are a few pros and cons worth considering before you make a decision on the stock for yourself.

Pros

  • Based on forecasts for 2015, the stock offers a fully franked 5% dividend yield. That鈥檚 much more appealing than the returns from a term deposit, or government bonds.
  • Investors still appear to be very attracted to the stock. This is likely due to its solid dividend yield as well its recent momentum.
  • The bank looks set to announce an annual cash profit of at least $8.5 billion for the first time in its history. Low interest rates and bad debt charges could see the good times continue in the near term.

Cons

  • Its dividend yield is topped by each of its rivals. Westpac Banking Corp (ASX: WBC) yields 5.6% while Australia and New Zealand Banking Group (ASX: ANZ) and National Australia Bank Ltd. (ASX: NAB) offer 5.5% and 6.4% respectively.
  • Further, any dividends received could well be offset by capital losses in the medium-to-long terms. Earnings are likely to come under pressure in the not-too-distant future which will likely see shares fall in price.
  • The bank鈥檚 reputation has been impacted by the scandal in its financial planning arm. This could result in independent advisors being less inclined to recommend the bank鈥檚 products.
  • Commonwealth Bank is heavily exposed to Australia鈥檚 booming housing market. Should cracks start to appear, this could prove very damaging for the bank.
  • Like each of the other banks, Commonwealth Bank is by no means a bargain. Trading on a P/E ratio of 14.5 (2015 forecast) and a Price-Book ratio of 2.91, the bank is well overpriced.

A better bet than Commonwealth Bank

Unfortunately, the cons seem to heavily outweigh the pros for buying Commonwealth Bank of Australia鈥檚 shares today. They would need to fall significantly in price before I would even consider buying a stake.

Motley Fool contributor Ryan Newman does not own shares in any of the companies mentioned.

More on 鈴革笍 Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
鈴革笍 Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
鈴革笍 Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more

asx share price competitions represented by businessmen arm wrestling
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more

asx investor daydreaming about US shares
鈴革笍 How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more

person reading news on mobile phone
鈴革笍 Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more